Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 PfenexEmblemTELIX PharmaceuticalRafaelResverlogix
SymbolNYSEAMERICAN:PFNXCVE:EMCASX:TLXNYSEAMERICAN:RFLTSE:RVX
Price Information
Current Price$7.32N/AA$1.47$14.94C$0.68
52 Week RangeBuyN/AN/AN/AN/A
Beat the Market™ Rank
Overall Score1.20.50.50.61.1
Analysis Score3.50.00.00.00.0
Community Score2.42.52.72.93.6
Dividend Score0.00.00.00.00.0
Ownership Score0.00.00.00.00.0
Earnings & Valuation Score0.00.00.00.01.9
Analyst Ratings
Consensus RecommendationBuyN/AN/AN/AN/A
Consensus Price Target$15.50N/AN/AN/AN/A
% Upside from Price Target111.75% upsideN/AN/AN/AN/A
Trade Information
Market Cap$185.13 million$248.31 million$372.56 million$186.34 millionC$158.04 million
BetaN/AN/AN/AN/AN/A
Average Volume341,015865,800N/A37,69671,667
Sales & Book Value
Annual RevenueN/A$5.71 million$3.49 millionN/AN/A
Price / SalesN/A0.00106.91N/AN/A
CashflowN/AN/AA$0.18 per shareN/AC$0.00 per share
Price / CashN/A4.088.35N/A840.00
Book ValueN/A$0.67 per shareA$0.28 per shareN/AC($0.36) per share
Price / BookN/A0.005.31N/AN/A
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSN/A($0.19)A($0.12)N/AC$0.23
Trailing P/E Ratio0.00N/AN/A0.002.92
Forward P/E RatioN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/A$0.46N/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/A N/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A30.01%3.04%N/AN/A
Current RatioN/A3.61%5.52%N/A0.15%
Quick RatioN/A3.24%5.42%N/A0.04%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees71N/AN/A18N/A
Shares Outstanding34.22 million132.08 million253.44 million15.82 million210.72 million
Next Earnings Date8/13/2020 (Estimated)N/AN/AN/A8/3/2020 (Estimated)
OptionableOptionableNot OptionableNot OptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.